ABSTRACT
Background Breast cancer is a global public health problem, representing a significant burden at the personal, collective, economic and quality of life level. It is necessary to consider the incidence, prevalence and mortality of this disease with a regional approach, so the objective of this work is to describe the epidemiological behavior of this tumor in the departments of the Colombian Caribbean Region during the period 2018 to 2021.
Methodology Descriptive, retrospective study. Data from a secondary source (Cuenta de Alto Costo) was taken through the Higia platform. Rates x 100,000 of proportion of new cases reported, prevalence and incidence, by departments are analyzed. Data was imported from a downloadable.csv file into Excel and then into SPSS V22.
Results The indicators analyzed showed a heterogeneous behavior in the 8 departments of the Region. Atlántico and Bolívar were the departments with similar and higher figures in the 4 years observed than those of the country and there were atypical values in San Andrés. La Guajira was the only department with a sustained tendency to increase in incidence, prevalence and mortality.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by Universidad Libre, seccional Barranquilla.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
